Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Change of Remuneration Committee Chair

17th Apr 2025 07:00

RNS Number : 3554F
Porvair PLC
17 April 2025
 

For immediate release 17 April 2025

 

Porvair plc

("Porvair" or the "Company")

 

Change of Remuneration Committee Chair

 

The Board of Porvair plc is pleased to announce that Sheena Mackay has succeeded Sally Martin as Chair of the Remuneration Committee with effect from 15 April 2025. Sally will continue to be the Senior Independent Director and a member of the Remuneration Committee, Nomination Committee and Audit Committee. Sally retains her responsibilities as the designated Director responsible for Employee Engagement.

 

Sheena joined the Board on 28 October 2024 as a Non-Executive Director and has been a member of the Remuneration Committee, Nomination Committee and Audit Committee since her appointment. Sheena is also a Non-Executive Director of Lords Group Trading plc, an Aim listed building material distributor, where she is Chair of the Remuneration Committee and Nomination Committee and a member of the Audit Committee. 

 

 

 

For further information, please contact:

 

Porvair plc

01553 765 500

Hooman Caman Javvi, Chief Executive

Chris Tyler, Group Company Secretary

Buchanan Communications

0207 466 5000

Charles Ryland / Stephanie Whitmore / Jack Devoy

 

Notes to Editors

Porvair is a group of specialist filtration, laboratory and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKLKFASSEFA

Related Shares:

Porvair
FTSE 100 Latest
Value8,275.66
Change0.00